Diabetic macular edema: New promising therapies

Figure 2 Horizontal spectral-domain optical coherence tomography scans of the macula before (A and B) and after (C and D) intravitreal bevacizumab therapy in a patient with diabetic macular edema. Note extensive cystoid macular edema in both eyes (A and B) and subretinal fluid in the right (A). Six months following treatment with 3 injections of bevacizumab, the macular edema almost completely resolved in both eyes (C and D). The Snellen visual acuity improved from 20/125 to 20/70 in the right eye, but did not change significantly in the left, likely due to atrophic changes in the outer retina as seen on optical coherence tomography.